{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T13:37:46Z","timestamp":1765546666548,"version":"3.37.3"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T00:00:00Z","timestamp":1599696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Immunol"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1038\/s41577-020-00428-4","type":"journal-article","created":{"date-parts":[[2020,9,10]],"date-time":"2020-09-10T17:03:07Z","timestamp":1599757387000},"page":"594-602","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":20,"title":["The global response to the COVID-19 pandemic: how have immunology societies contributed?"],"prefix":"10.1038","volume":"20","author":[{"given":"Faith","family":"Osier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7846-0395","authenticated-orcid":false,"given":"Jenny P. Y.","family":"Ting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bart N.","family":"Lambrecht","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Romano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo T.","family":"Gazzinelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6780-5397","authenticated-orcid":false,"given":"Karina R.","family":"Bortoluci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7856-7512","authenticated-orcid":false,"given":"Dario S.","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3763-9380","authenticated-orcid":false,"given":"Arne N.","family":"Akbar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Doug E.","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamala D.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuzhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana B.","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oliver","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Kamradt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christine","family":"Falk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mira","family":"Barda-Saad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7469-5728","authenticated-orcid":false,"given":"Amiram","family":"Ariel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Annunziato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco A.","family":"Cassatella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5150-1011","authenticated-orcid":false,"given":"Hiroshi","family":"Kiyono","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valeriy","family":"Chereshnev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alioune","family":"Dieye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moustapha","family":"Mbow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Babacar","family":"Mbengue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3290-0698","authenticated-orcid":false,"given":"Maguette D. S.","family":"Niang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6978-4654","authenticated-orcid":false,"given":"Melinda","family":"Suchard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2020,9,10]]},"reference":[{"key":"428_CR1","unstructured":"International Union of Immunological Societies. IUIS-Frontiers webinar series on COVID-19. IUIS https:\/\/iuis.org\/webinars\/ (2020)."},{"key":"428_CR2","unstructured":"The American Association of Immunologists. The American Association of Immunologists, public affairs. AAI https:\/\/www.aai.org\/Public-Affairs (2020)."},{"key":"428_CR3","unstructured":"The American Association of Immunologists. Letter from the American Association of Immunologists. AAI https:\/\/www.aai.org\/AAISite\/media\/Public_Affairs\/Letters-Comments\/Letter-from-The-American-Association-of-Immunologists-re-COVID-19.pdf (2020)."},{"key":"428_CR4","unstructured":"The American Association of Immunologists. Letter to Dr Collins regarding grant termination. AAI https:\/\/www.aai.org\/AAISite\/media\/Public_Affairs\/Letters-Comments\/Letter_to_Dr_Collins_Re_Grant_Termination_052020.pdf (2020)."},{"key":"428_CR5","unstructured":"The American Association of Immunologists. Statement of AAI Committee on Public Affairs. AAI https:\/\/www.aai.org\/AAISite\/media\/Public_Affairs\/Letters-Comments\/AAI-Opposes-US-Withdrawal-from-WHO-and-Visa-Changes-Affecting-Chinese-Scientists-060920.pdf (2020)."},{"key":"428_CR6","unstructured":"The Journal of Immunology COVID-19, SARS, and MERS articles. J. Immunol. https:\/\/www.jimmunol.org\/coronaviruses"},{"key":"428_CR7","unstructured":"The Journal of Immunology. A message to our authors, reviewers, and readers. J. Immunol. https:\/\/www.jimmunol.org\/content\/message-our-authors-reviewers-and-readers7 (2020)."},{"key":"428_CR8","unstructured":"The American Association of Immunologists. Poster abstracts from IMMUNOLOGY2020. AAI https:\/\/plan.core-apps.com\/aai2020\/abstracts (2020)."},{"key":"428_CR9","unstructured":"The American Association of Immunologists. COVID-19 resources and information center. AAI https:\/\/www.aai.org\/COVID-19-Resources (2020)."},{"key":"428_CR10","unstructured":"The American Association of Immunologists. AAI Courses in immunology. AAI https:\/\/www.aai.org\/Education\/Courses (2020)."},{"key":"428_CR11","unstructured":"The American Association of Immunologists. AAI Fellowships. AAI https:\/\/www.aai.org\/Careers\/Fellowships\/ (2020)."},{"key":"428_CR12","unstructured":"The Australian and New Zealand Society for Immunology. ASI community. ASI https:\/\/www.immunology.org.au\/community\/ (2020)."},{"key":"428_CR13","unstructured":"The Australian and New Zealand Society for Immunology. ASI Fireside chats. ASI https:\/\/www.immunology.org.au\/events\/list\/ (2020)."},{"key":"428_CR14","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04451-7","volume":"21","author":"C Bosteels","year":"2020","unstructured":"Bosteels, C. et al. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials 21, 491 (2020).","journal-title":"Trials"},{"key":"428_CR15","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-020-04453-5","volume":"21","author":"B Maes","year":"2020","unstructured":"Maes, B. et al. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): a structured summary of a study protocol for a randomised controlled trial. Trials 21, 468 (2020).","journal-title":"Trials"},{"key":"428_CR16","unstructured":"US National Library of Medicine. ClinicalTrials.gov https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT04382755 (2020)."},{"key":"428_CR17","unstructured":"Sociedade Brasiliera de Imunologia. SBI homepage. SBI https:\/\/sbi.org.br\/ (2020)."},{"key":"428_CR18","unstructured":"British Society for Immunology. Information on the Joint Academy of Medical Sciences\/British Society for Immunology Taskforce: https:\/\/www.immunology.org\/coronavirus\/immunology-and-covid-19 (2020)."},{"key":"428_CR19","unstructured":"British Society for Immunology. Joint Academy of Medical Sciences\/British Society for Immunology report on COVID-19 and immunology https:\/\/www.immunology.org\/sites\/default\/files\/Final_COVID-19_Immunology_report.pdf (2020)."},{"key":"428_CR20","unstructured":"British Society for Immunology. Coronavirus information hub on the BSI website. BSI https:\/\/www.immunology.org\/coronavirus (2020)."},{"key":"428_CR21","unstructured":"British Society for Immunology. BSI \u2018Connect on Coronavirus\u2019 webinar series. BSI https:\/\/www.immunology.org\/coronavirus\/connect-coronavirus-webinars (2020)."},{"key":"428_CR22","unstructured":"Canadian Society for Immunology. CSI Council statement on systemic inequities. CSI https:\/\/www.csi-sci.ca\/ (2020)."},{"key":"428_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1093\/infdis\/jiaa243","volume":"222","author":"XF Cai","year":"2020","unstructured":"Cai, X. F. et al. A peptide-based magnetic chemiluminescence enzyme immunoassay for serological diagnosis of coronavirus disease 2019. J. Infect. Dis. 222, 189\u2013193 (2020).","journal-title":"J. Infect. Dis."},{"key":"428_CR24","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.07.20032524","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Diagnosis of acute respiratory syndrome coronavirus 2 infection by detection of nucleocapsid protein. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.07.20032524 (2020).","journal-title":"medRxiv"},{"key":"428_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/science.abc1932","author":"Q Gao","year":"2020","unstructured":"Gao, Q. et al. Rapid development of an inactivated vaccine candidate for SARS-CoV-2. Science https:\/\/doi.org\/10.1126\/science.abc1932 (2020).","journal-title":"Science"},{"key":"428_CR26","doi-asserted-by":"publisher","first-page":"1845","DOI":"10.1016\/S0140-6736(20)31208-3","volume":"395","author":"FC Zhu","year":"2020","unstructured":"Zhu, F. C. et al. Safety, tolerability, and immunogenicity of a recombinant adenovirus type-5 vectored COVID-19 vaccine: a dose-escalation, open-label, non-randomised, first-in-human trial. Lancet 395, 1845\u20131854 (2020).","journal-title":"Lancet"},{"key":"428_CR27","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1038\/s41423-020-0426-7","volume":"17","author":"XY Chen","year":"2020","unstructured":"Chen, X. Y. et al. Human monoclonal antibodies block the binding of SARS-CoV-2 spike protein to angiotensin converting enzyme 2 receptor. Cell. Mol. Immunol. 17, 647\u2013649 (2020).","journal-title":"Cell. Mol. Immunol."},{"key":"428_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.05.025","author":"Y Cao","year":"2020","unstructured":"Cao, Y. et al. Potent neutralizing antibodies against SARS-CoV-2 identified by high-throughput single-cell sequencing of convalescent patients\u2019 B cells. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.05.025 (2020).","journal-title":"Cell"},{"key":"428_CR29","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1126\/science.abc2241","volume":"368","author":"Y Wu","year":"2020","unstructured":"Wu, Y. et al. A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2. Science 368, 1274\u20131278 (2020).","journal-title":"Science"},{"key":"428_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/10.1038\/s41586-020-2312-y","author":"L Bao","year":"2020","unstructured":"Bao, L. et al. The pathogenicity of SARS-CoV-2 in hACE2 transgenic mice. Nature https:\/\/doi.org\/10.1016\/10.1038\/s41586-020-2312-y (2020).","journal-title":"Nature"},{"key":"428_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2020.06.010","author":"J Sun","year":"2020","unstructured":"Sun, J. et al. Generation of a broadly useful model for COVID-19 pathogenesis, vaccination, and treatment. Cell https:\/\/doi.org\/10.1016\/j.cell.2020.06.010 (2020).","journal-title":"Cell"},{"key":"428_CR32","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","volume":"11","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19). Front. Immunol. 11, 827 (2020).","journal-title":"Front. Immunol."},{"key":"428_CR33","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1038\/s41591-020-0897-1","volume":"26","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Antibody responses to SARS-CoV-2 in patients with COVID-19. Nat. Med. 26, 845\u2013848 (2020).","journal-title":"Nat. Med."},{"key":"428_CR34","doi-asserted-by":"publisher","DOI":"10.1038\/s41591-020-0965-6","author":"QX Long","year":"2020","unstructured":"Long, Q. X. et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat. Med. https:\/\/doi.org\/10.1038\/s41591-020-0965-6 (2020).","journal-title":"Nat. Med."},{"key":"428_CR35","doi-asserted-by":"publisher","DOI":"10.1101\/2020.03.04.20031120","author":"B Diao","year":"2020","unstructured":"Diao, B. et al. Human kidney is a target for novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.03.04.20031120 (2020).","journal-title":"medRxiv"},{"key":"428_CR36","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","volume":"7","author":"Y Zhou","year":"2020","unstructured":"Zhou, Y. et al. Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients. Natl Sci. Rev. 7, 998\u20131002 (2020).","journal-title":"Natl Sci. Rev."},{"key":"428_CR37","doi-asserted-by":"publisher","unstructured":"Liu, Y. et al. Thymosin alpha 1 (T\u03b11) reduces the mortality of severe COVID-19 by restoration of lymphocytopenia and reversion of exhausted T cells. Clin. Infect. Dis. https:\/\/doi.org\/10.1093\/cid\/ciaa630 (2020).","DOI":"10.1093\/cid\/ciaa630"},{"key":"428_CR38","doi-asserted-by":"publisher","first-page":"10970","DOI":"10.1073\/pnas.2005615117","volume":"117","author":"X Xu","year":"2020","unstructured":"Xu, X. et al. Effective treatment of severe COVID-19 patients with tocilizumab. Proc. Natl Acad. Sci. USA 117, 10970\u201310975 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"428_CR39","unstructured":"D\u00edaz-Canel Berm\u00fadez, M., N\u00fa\u00f1ez Jover, J. Government management and Cuban science in the confrontation with COVID-19. An. Acad. Cienc. Cuba. http:\/\/www.revistaccuba.cu\/index.php\/revacc\/article\/view\/881\/892 (2020)."},{"key":"428_CR40","doi-asserted-by":"publisher","first-page":"31","DOI":"10.37757\/MR2020.V22.N2.9","volume":"22","author":"L Castellanos-Serra","year":"2020","unstructured":"Castellanos-Serra, L. Bringing Cuban Biotech Research to Bear on COVID-19: All Hands and Minds on Deck. MEDICC Rev. 22, 31\u201337 (2020).","journal-title":"MEDICC Rev."},{"key":"428_CR41","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.29.20109199","author":"R Pereda","year":"2020","unstructured":"Pereda, R., et al. Therapeutic effectiveness of interferon-alpha2b against COVID-19: the Cuban experience. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.05.29.20109199 (2020).","journal-title":"medRxiv"},{"key":"428_CR42","doi-asserted-by":"publisher","unstructured":"Saavedra, D., et al. An anti-CD6 monoclonal antibody (itolizumab) reduces circulating IL-6 in severe covid-19 elderly patients. Immun. Ageing https:\/\/doi.org\/10.21203\/rs.3.rs-32335\/v1 (2020).","DOI":"10.21203\/rs.3.rs-32335\/v1"},{"key":"428_CR43","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.27.20110601","author":"R Venegas-Rodr\u00edguez","year":"2020","unstructured":"Venegas-Rodr\u00edguez, R., et al. CIGB-258 immunomodulatory peptide: a novel promising treatment for critical and severe COVID-19 patients. Preprint at medRxiv https:\/\/doi.org\/10.1101\/2020.05.27.20110601 (2020).","journal-title":"medRxiv"},{"key":"428_CR44","unstructured":"Accademia Nazionale dei Lincei. COVID19: An executive report. https:\/\/www.lincei.it\/it\/article\/covid-19-executive-report (2020)."},{"key":"428_CR45","unstructured":"Societ\u00e0 Italiana diImmunologia, Immunologia Clinica e Allergologia. SIICA SCHOOL, official channel. Youtube https:\/\/www.youtube.com\/channel\/UCh5jjFh6tOARju4IKlvUHKQ (2020)."},{"key":"428_CR46","unstructured":"Gavi, the Vaccine Alliance. The GAVI COVAX AMC. Gavi https:\/\/www.gavi.org\/sites\/default\/files\/2020-06\/Gavi-COVAX-AMC-IO.pdf (2020)."},{"key":"428_CR47","unstructured":"The Japanese Society of Immunology. Letter of solidarity and support from the Japanese Society of Immunology. JSI http:\/\/files.jsi-men-eki.org\/general\/meneki\/JSI_Message_20200327.pdf (2020)."},{"key":"428_CR48","unstructured":"The Japanese Society of Immunology. Homepage for the 49th Meeting of the Japanese Society for Immunology. JSI http:\/\/icongroup.co.jp\/49immunology\/english\/ (2020)."},{"key":"428_CR49","unstructured":"Japanese Agency for Medical Research and Development. AMED new scientific outputs related to COVID-19. AMED https:\/\/www.amed.go.jp\/en\/news\/topics\/nso-index.html (2020)."}],"container-title":["Nature Reviews Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00428-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00428-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,9]],"date-time":"2021-09-09T23:38:29Z","timestamp":1631230709000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41577-020-00428-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["428"],"URL":"https:\/\/doi.org\/10.1038\/s41577-020-00428-4","relation":{},"ISSN":["1474-1733","1474-1741"],"issn-type":[{"type":"print","value":"1474-1733"},{"type":"electronic","value":"1474-1741"}],"subject":[],"published":{"date-parts":[[2020,9,10]]},"assertion":[{"value":"6 August 2020","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 September 2020","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"J.P.Y.T. is a co-founder of IMMvention Therapeutix and Goldcrest Bio. All other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}